Recursion Pharmaceuticals (RXRX) Proxy filing summary

Voting matters and shareholder proposals

• Election of two directors: Najat Khan, Ph.D. and Franziska Michor, Ph.D., with board recommending a vote in favor.

• Advisory vote on executive compensation, with board recommending approval.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026, recommended by the board.

• Additional business may be addressed if properly brought before the meeting.

Board of directors and corporate governance

• Board nominees for election include Najat Khan, Ph.D. and Franziska Michor, Ph.D.

Executive compensation and say-on-pay

• Advisory vote scheduled to approve executive compensation as disclosed in the 2026 Proxy Statement.